Why Does Longview Like General Dynamics?

James A. Star’s Longview Asset Management likes General Dynamics Corporation (NYSE:GD), an aerospace and defense company, a lot. At the end of June the fund reported owning over 33 million shares of the stock, and its position in General Dynamics was valued at over $2 billion (see other stocks that Longview owns). Since that time the stock is up about 2%. According to our database of 13F filings, this was by far the largest position in the stock. The next largest was the 3.9 million shares owned by Warren Buffett’s Berkshire Hathaway (find other stocks in Warren Buffett’s portfolio). Both Berkshire and Longviews’s positions were unchanged from the beginning of April. Billionaire Thomas Steyer’s Farallon Capital increased its stake in the second quarter, to a total of 1.1 million shares.

Warren Buffett portrait

The first half of the year showed little change on the top line for General Dynamics Corporation, as its revenue only rose by 1%. Operating earnings edged up a bit higher, and other income helped drive earnings per share up by a total of 2%. General Dynamics consists of four major operating segments which earned between $2.7 billion and $5.6 billion during the first six months of 2012. Information Systems and Technology, the largest of these, is growing: revenue rose 13%, and operating income increased from $444 million to $575 million. The second largest segment, Combat Systems (which provides combat vehicles such as tanks), also showed growth. Essentially, the larger segments are growing and the smaller segments are shrinking- which, if this trend continues, would result in an increased growth rate going forward.

Obviously, potential investors should have mentally pointed out by now that General Dynamics Corporation is highly dependent on military spending by the U.S. government (according to the company’s 10-Q, over 2/3 of revenue comes from the federal government) and that under current law there will be significant cuts to spending starting in 2013. This is something that we would expect to harm the business as a whole. The market, which prices General Dynamics at 10 times trailing earnings despite a dividend yield of 3.0%, seems to be counting on such a decline in the company’s business. Wall Street analysts don’t think that spending cuts will have much of an effect, and the forward P/E based on their estimates is actually even lower at 9.

Given the dynamics (sorry) of the company’s revenue, it is probably optimal to compare it to defense-oriented peers which face the same federal spending related challenges. We would include The Boeing Company (NYSE:BA), Lockheed Martin Corporation (NYSE:LMT), Textron Inc. (NYSE:TXT), and Northrop Grumman Corporation (NYSE:NOC) to make for a good peer group. Textron is growing nicely, and its product base is somewhat diversified, but it carries a quite high price premium relative to the rest of the companies we’ve mentioned: its trailing P/E is 18, with the next highest being Boeing (which, of course, is also somewhat diversified from dependence on the federal government) at 12. The forward P/E at Textron, however, is only 11 and we think it could be worth studying further. Boeing, meanwhile, is expected to see stagnant business over the next year leading to no change in its P/E. Its recent earnings growth has been very low as well.

Lockheed Martin and Northrop Grumman represent more purely defense-oriented companies than Boeing or Textron. Their dividend yields trump that of General Dynamics: slightly, at 3.2%, in the case of Northrop Grumman; by a substantial amount, at 4.9%, at Lockheed Martin. Northrop Grumman is about even with General Dynamics on an earnings basis, while Lockheed Martin carries a slight premium at 11 times both its trailing earnings and analyst consensus for 2013. Unless an income investor is very excited about Lockheed Martin’s dividend yield, we don’t see much to recommend any of these companies relative to each other- they seem to trade in a very narrow range.

General Dynamics, Lockheed Martin, and Northrop Grumman look pretty alike: cheap on a historical basis, but facing significant challenges in terms of spending cuts from the U.S. government. Boeing and Textron are safer, but seem to carry valuation premiums about in line with their relative advantages. Unless Textron’s growth story continues, none of these companies looks like a particularly confident buy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!